Monoclonal antibodies as potential COVID-19 therapeutic agents

J Plichta, P Kuna, M Panek - COVID, 2022 - mdpi.com
… damaging symptoms associated with COVID-19, thus reducing … mainstream therapeutic
agents in the treatment of COVID-19. … of becoming COVID-19 therapeutics are discussed [6]. …

An update on current therapeutic drugs treating COVID-19

R Wu, L Wang, HCD Kuo, A Shannar, R Peter… - Current pharmacology …, 2020 - Springer
… , and oseltamivir), and supporting agents (Ascorbic acid, Azithromycin, … therapeutic drugs
to prevent, control, and treat COVID-19 … promising therapeutic agent against COVID-19 [124]. …

Withaferin A: A potential therapeutic agent against COVID-19 infection

AR Straughn, SS Kakar - Journal of Ovarian Research, 2020 - Springer
… spread of the novel coronavirus disease 2019 (COVID-19) is a … COVID-19. Therefore, WFA
demonstrates real potential as a therapeutic agent to treat or prevent the spread of COVID-19

Therapeutic advances in COVID-19

N Murakami, R Hayden, T Hills, H Al-Samkari… - Nature Reviews …, 2023 - nature.com
Therapeutic agents investigated during the pandemic include medications with diverse
mechanisms of action, such as antiviral therapies that inhibit viral replication directly, …

COVID-19: Therapeutics and interventions currently under consideration

RB McFee - Disease-a-Month, 2020 - Elsevier
… against COVID-19, which we highlight, again with varying results. In addition to therapeutics,
… As with any therapeutic agent trialed against COVID-19 be alert to adaptations in dosing …

[PDF][PDF] COVID-19 therapeutic and prevention

D Raoult, PR Hsueh, S Stefani, JM Rolain - … journal of antimicrobial agents, 2020 - Elsevier
We are publishing a special issue dedicated to the coronavirus, in all its aspects of management
and treatment. Indeed, in the 21st century, it is necessary to share data as quickly as …

Potential therapeutic agents for COVID-19 based on the analysis of protease and RNA polymerase docking

YC Chang, YA Tung, KH Lee, TF Chen, YC Hsiao… - 2020 - preprints.org
… This study aims to determine whether the protease of COVID-19 can be a target protein for
agents for potential binding with RNA-dependent RNA polymerase (RdRp) of COVID-19 in …

Review of therapeutic agents for the treatment of COVID-19

S Ziaie, M Koucheck, MM Miri, S Salarian… - Journal of Cellular & …, 2020 - ojs3.sbmu.ac.ir
In late December 2019, a cluster of unexplained pneumonia cases has been reported in
Wuhan, China, named coronavirus disease 2019 (COVID-19) which has been spreading in 204 …

Use of natural compounds as a potential therapeutic agent against COVID-19

S Wahab, I Ahmad, S Irfan, MH Baig… - Current …, 2021 - ingentaconnect.com
… for COVID19 treatment are contrasting; therefore, the use of these drugs to treat and prevent
COVID-19 is … glycyrrhizinate and vitamin C for COVID-19 therapy in China. Glycyrrhizin is a …

Potential therapeutic options for COVID-19: an update on current evidence

Z Niknam, A Jafari, A Golchin, F Danesh Pouya… - European journal of …, 2022 - Springer
… and safety for COVID-19 treatment. We tried to … therapeutic approaches against COVID-19
to support researchers and physicians in any current and future progress in treating COVID-19